Agenus (AGEN) Stock: Gaining On Subsidiary Creation
Agenus Inc (NASDAQ: AGEN) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced the creation of a new subsidiary surrounding its cell therapy business. This led to excitement among investors, sending the stock screaming for the top. Of course, our partners at Trade Ides were … Read more